InvestorsHub Logo
Followers 43
Posts 2425
Boards Moderated 0
Alias Born 02/09/2016

Re: StockBroker42069 post# 65606

Tuesday, 04/07/2020 11:11:05 AM

Tuesday, April 07, 2020 11:11:05 AM

Post# of 233145
StockBroker32069- From CYDY site- https://www.cytodyn.com/newsroom/press-releases/detail/410/cytodyn-collaborating-with-u-k-s-department-of-health-to

April 7, 2020
CytoDyn Collaborating with U.K.’s
Department of Health to Provide
Emergency Access to Leronlimab for
Severe and Critically Ill COVID-19 Patients
CEO Nader Pourhassan will appear on FOX Business Network on April 7
at 11:00 am PT to provide an update on the Company’s two COVID-19
clinical trials and 15 patients on EIND
VANCOUVER, Washington, April 07, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc.
(OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company
developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple
therapeutic indications, announced today that it is collaborating with the U.K.’s Department
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News